Genome Sequencing in Public Health: Sharon Peacock on MRSA Outbreaks, TB Resistance and the UK COVID Genomics Project

Overview

In the podcast, Chris Smith chats with microbiologist Professor Sharon Peacock about how genome sequencing has transformed public health, outbreak investigations, and clinical decision making. Peacock traces her unusual career path from dental nursing to medicine and infectious diseases, and explains how sequencing pathogens can reveal transmission links and resistance patterns. The discussion covers key milestones from MRSA outbreaks to the COVID-19 pandemic and the UK-wide genomics network that drove real-time insight into viral evolution.

• Genome sequencing can pinpoint hospital transmission chains far faster than traditional shoe leather epidemiology.
• Sequencing supports rapid antibiotic stewardship and helps predict drug resistance in diseases like TB and HIV.
• COG-UK established a nationwide sequencing capability across public health and academia to monitor SARS-CoV-2 variants.
• The interview also reflects Peacock’s leadership shift to Cambridge and her championing outreach and long-term institutional resilience.

Background and Career Path

The podcast begins with a portrait of Sharon Peacock, a leading figure in infectious diseases research, who started life as a dental nurse and general nurse before training as a physician. Peacock describes how environment and persistence shaped her journey from clinical care to medical science, culminating in a PhD that fused medicine with laboratory genetics. She explains how whole genome sequencing became her gateway to answering practical clinical and public health questions about how pathogens vary and spread.

Foundations of Genome Sequencing in Public Health

Peacock recounts the early, transitionary period when sequencing moved from little-capacity, specialist centers to something accessible in routine clinical labs. She outlines two core questions that motivated her work: first, can sequencing of pathogens from different patients reveal outbreak clusters with greater certainty than traditional epidemiology, and second, can we infer antibiotic susceptibility from genomic data to accelerate treatment decisions, especially for tuberculosis?

MRSA Outbreak Detective Work

The first concrete demonstration involved MRSA outbreaks on a neonatal intensive care unit. By sequencing MRSA isolates, Peacock showed that the infant group represented a real outbreak and traced links to carriage among parents and staff. This forensic genomic epidemiology revealed transmission pathways that would likely have been missed with conventional methods, enabling quicker and more precise interventions to stop further spread.

Expanding the Role: TB and HIV

The discussion moves to TB, where sequencing of the genome could predict drug resistance, dramatically shortening the time to determine effective therapy. Peacock notes that the UK was among the early adopters of routine sequencing to guide TB treatment. She also highlights how sequencing informs HIV treatment by monitoring resistance patterns in circulating viruses, a critical step for long-term therapy management.

From Outbreaks to a National Surveillance Network

With the onset of the COVID-19 pandemic, Peacock explains how she helped build a national sequencing capability in the UK by linking four public health agencies, 16 universities, the Sanger Institute, and 100 NHS testing labs into a cohesive network. The aim was to sequence around 10% of known positive cases and share data securely to track the virus’s evolution, variants, and potential impacts on transmission, disease severity, and vaccine effectiveness. The data were deposited in a secure national database and, anonymously, into international databases to enable global analysis.

Outcomes and Legacy

The open, large-scale sequencing approach demonstrated that pathogen genomics could function as a real-time radar for a country, guiding public health decision making and policy during the pandemic. Peacock reflects on lessons learned, including the need for rapid action, scalable infrastructure, and automated bioinformatics support to translate genome data into actionable insights for public health agencies.

Leadership and Cambridge

After the pandemic, Peacock transitioned to leadership roles at Churchill College, Cambridge, driven by a commitment to outreach and access. She discusses her motivation to support young people from diverse backgrounds and to ensure the college remains a vibrant place for innovation and education for decades to come. The talk ends with reflections on balancing an active research agenda with governance duties and ongoing public service commitments.